Skip to main content
PURPLE BIOTECH LTD. logo

PURPLE BIOTECH LTD. — Investor Relations & Filings

Ticker · PPBT ISIN · US74638P1093 US Manufacturing
Filings indexed 556 across all filing types
Latest filing 2026-05-15 Foreign Filer Report
Country US United States of America
Listing US PPBT

About PURPLE BIOTECH LTD.

https://purple-biotech.com/

Purple Biotech Ltd. is a clinical-stage company focused on developing first-in-class therapies for cancer patients. The company's approach centers on overcoming tumor immune evasion and drug resistance by targeting the tumor microenvironment. Its development pipeline includes several therapeutic candidates, such as NT219, a dual inhibitor designed to overcome drug resistance, and CM24, a monoclonal antibody targeting the immune checkpoint CEACAM1. These programs aim to provide more effective and durable treatment options for various types of cancer.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2026-05-15 English
6-K - PURPLE BIOTECH LTD. (0001614744) (Filer)
Foreign Filer Report
2026-04-27 English
6-K - PURPLE BIOTECH LTD. (0001614744) (Filer)
Foreign Filer Report
2026-04-23 English
3 - PURPLE BIOTECH LTD. (0001614744) (Issuer)
Director's Dealing
2026-03-30 English
3 - PURPLE BIOTECH LTD. (0001614744) (Issuer)
Director's Dealing
2026-03-27 English
6-K - PURPLE BIOTECH LTD. (0001614744) (Filer)
Foreign Filer Report
2026-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.